Article

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer

2021-03-26

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> In 2021, a joint ESGO/ESTRO/ESP committee updated their evidence-based guidelines for endometrial cancer, recommending a new risk grouping incorporating both clinicopathologic and molecular parameters. We applied the new risk grouping and compared the results to those of the prior 2016 clinicopathologic system. <h4>Materials and methods</h4> We classified molecularly a cohor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 16fdecd3-b358-52d9-ac0e-cb6af5ef2339
DOI: 10.1101/2021.03.25.21254244

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancerDOI 10.1101/2021.03.25.21254244Read

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.Semantic proximity Read

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read

Analysis of Differences in the Classification of Endometrial Cancer Patients in PolandSemantic proximity Read

Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer.Semantic proximity Read

FIGO 2023 staging system with/without molecular classification vs. FIGO 2009 in 172 endometrial cancer patients.Semantic proximity Read

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read

FIGO 2023 Staging and Molecular Classification of 172 patients with Endometrial CancerSemantic proximity Read

Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer.Semantic proximity Read

Molecular classification-driven stage migration and prognostic risk stratification in endometrial cancers: FIGO 2023 vs FIGO 2009.Semantic proximity Read

New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.Semantic proximity Read

Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer.Semantic proximity Read

Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohortSemantic proximity Read